Beam Therapeutics (BEAM) Preferred Dividend Payments (2019 - 2020)
Beam Therapeutics (BEAM) reported Preferred Dividend Payments of $1.3 million for Q1 2020, down 56.9% year-over-year from $3.0 million in Q2 2019, and down 60.86% quarter-over-quarter from $3.3 million in Q4 2019.
Beam Therapeutics (BEAM) Preferred Dividend Payments (2019 - 2020) Analysis & Trends
Beam Therapeutics (BEAM) has 2 years of Preferred Dividend Payments data on file, last reported at $1.3 million in Q1 2020.
- Preferred Dividend Payments for Q1 2020 came in at $1.3 million, down 56.9% year-over-year; the trailing twelve-month figure through Dec 2020 was $1.3 million (down 89.96% YoY), and the FY2020 annual result was $1.3 million, down 89.96% from the prior year.
- Preferred Dividend Payments declined to $1.3 million in Q1 2020 per BEAM's latest filing, from $3.3 million in the prior quarter.
- Over five years, Preferred Dividend Payments peaked at $3.3 million in Q4 2019 and troughed at $1.3 million in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Beam Therapeutics | 3.53 Bn | 3.53 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 1.28 Mn |
| Dec 31, 2019 | 3.26 Mn |
| Sep 30, 2019 | 3.26 Mn |
| Jun 30, 2019 | 3.23 Mn |
| Mar 31, 2019 | 2.96 Mn |